INTERPACE BIOSCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Interpace Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Interpace Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $2.06M, a 1078% increase year-over-year.
  • Interpace Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $2.81M.
  • Interpace Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $802K.
  • Interpace Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$22M, a 46.9% decline from 2021.
  • Interpace Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.9M, a 43.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.81M $2.06M +$1.89M +1078% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $919K $468K +$117K +33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 $802K $890K +$2.45M Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$1.65M -$614K +$13.6M +95.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$15.2M $175K +$4.11M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$19.4M $351K +$2.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$22M -$1.56M +$2.17M +58.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$24.1M -$14.2M -$10.6M -299% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$13.5M -$3.94M -$493K -14.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$13M -$2.25M +$1.96M +46.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$14.9M -$3.73M +$4.41M +54.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$19.4M -$3.56M +$2.67M +42.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$22M -$3.45M +$2.13M +38.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$24.2M -$4.21M +$2.29M +35.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$26.5M -$8.14M +$2.52M +23.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-04-01
Q3 2020 -$29M -$6.23M +$1.21M +16.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$30.2M -$5.58M -$276K -5.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$29.9M -$6.49M -$3.17M -95.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$26.7M -$10.7M -$6.36M -148% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 -$20.4M -$7.45M -$4.32M -138% Jul 1, 2019 Sep 30, 2019 10-K 2021-04-01
Q2 2019 -$16.1M -$5.3M -$3.3M -165% Apr 1, 2019 Jun 30, 2019 10-K 2021-04-01
Q1 2019 -$12.8M -$3.33M -$49K -1.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-04-01
Q4 2018 -$12.7M -$4.3M -$24.3M -121% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 $11.6M -$3.13M +$274K +8.06% Jul 1, 2018 Sep 30, 2018 10-K/A 2021-01-19
Q2 2018 $11.3M -$2M +$4.39M +68.7% Apr 1, 2018 Jun 30, 2018 10-K/A 2021-01-19
Q1 2018 $6.95M -$3.28M -$5.61M -241% Jan 1, 2018 Mar 31, 2018 10-K/A 2021-01-19
Q4 2017 $12.6M $20M +$25.9M Oct 1, 2017 Dec 31, 2017 10-K/A 2021-01-19
Q3 2017 -$13.3M -$3.4M +$4.6M +57.5% Jul 1, 2017 Sep 30, 2017 10-K/A 2021-01-19
Q2 2017 -$17.9M -$6.39M -$3.55M -125% Apr 1, 2017 Jun 30, 2017 10-K/A 2021-01-19
Q1 2017 -$14.4M $2.33M +$7.63M Jan 1, 2017 Mar 31, 2017 10-K/A 2021-01-19
Q4 2016 -$22M -$5.86M -$9.74M -251% Oct 1, 2016 Dec 31, 2016 10-K/A 2021-01-19
Q3 2016 -$12.3M -$8M -$2.6M -48.1% Jul 1, 2016 Sep 30, 2016 10-K/A 2021-01-19
Q2 2016 -$9.66M -$2.84M +$4.64M +62% Apr 1, 2016 Jun 30, 2016 10-K/A 2021-01-19
Q1 2016 -$14.3M -$5.3M -$682K -14.8% Jan 1, 2016 Mar 31, 2016 10-K/A 2021-01-19
Q4 2015 -$13.6M $3.88M +$11.9M Oct 1, 2015 Dec 31, 2015 10-K/A 2021-01-19
Q3 2015 -$25.6M -$5.41M -$951K -21.4% Jul 1, 2015 Sep 30, 2015 10-K/A 2021-01-19
Q2 2015 -$24.6M -$7.49M -$4.83M -182% Apr 1, 2015 Jun 30, 2015 10-K/A 2021-01-19
Q1 2015 -$19.8M -$4.61M -$3M -186% Jan 1, 2015 Mar 31, 2015 10-K/A 2021-01-19
Q4 2014 -$16.8M -$8.04M -$4.38M -119% Oct 1, 2014 Dec 31, 2014 10-K/A 2021-01-19
Q3 2014 -$12.4M -$4.45M -$2.31M -108% Jul 1, 2014 Sep 30, 2014 10-K/A 2021-01-19
Q2 2014 -$10.1M -$2.66M -$1.78M -201% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$8.3M -$1.61M -$3.74M -176% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$4.57M -$3.67M +$20.1M +84.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 -$24.7M -$2.14M -$1.12M -110% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$23.6M -$883K -$444K -101% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$23.1M $2.13M +$2.4M Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-08-19
Q4 2012 -$25.5M -$23.8M -$13.5M -132% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 -$12M -$1.02M -$817K -404% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-09-30
Q2 2012 -$11.2M -$439K +$456K +51% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 -$11.6M -$272K +$278K +50.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$11.9M -$10.3M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$202K +$1.47M +87.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$895K -$5K -0.56% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$550K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.67M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$890K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.